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Background. This study is part of the European Community Respiratory Health Survey (ECRHS), which uses 
a common methodology in different areas throughout the world. This paper describes the prevalences of 
reported asthma, asthma-like symptoms and nasal allergies, their relationships to age group and sex, and the 
relationships of asthma-like symptoms to current asthma, in the general population aged 2044 years of three 
French urban areas. 
Methods. The study population of 2804 subjects in Grenoble, 3774 in Montpellier and 3152 in Paris (18th 
district), randomly selected from electoral rolls, answered a postal questionnaire (stage I of ECRHS). The 
response rates were 77+3%, 68.6% and 74.4%, respectively. 
Results. The prevalences were approximately 14% for wheezing, 16% for chest tightness and 4.5% for 
nocturnal shortness of breath in the three areas. Asthma attacks in the last 12 months were reported by 2.7% 
of subjects in Grenoble, 3.5% of subjects in Montpellier and 4.0% of subjects in Paris (P=O.O2). For nasal 
allergies, the prevalences were 2&O%, 34.3% and 30.8%, respectively (P<O.OOl). Asthma was inversely 
correlated to age (higher prevalence in the youngest) but was not related to sex. Neither age distribution nor 
sex ratio explained the differences between areas. Among the asthma-like symptoms, wheezing and nocturnal 
shortness of breath correlated strongly with asthma, chest tightness correlated moderately and nocturnal 
coughing correlated poorly. 
Conclusion. The prevalences observed were higher than expected from previous comparable French studies 
in young adults. These results are consistent with the hypothesis of a recent increase of asthma and allergies. 
Introduction 
Asthma is an increasingly serious cause of morbid- 
ity in many countries, and mortality rates associated 
with asthma have been increasing since the mid- 
1970s especially in 5-34-year-olds (1,2). Hospital 
admissions have increased even more substantially, 
particularly among children (3). These consequences 
may be due to artefacts of procedure, but are more 
likely to be due to changes in prevalence or severity 
of the disease (4). Nevertheless the only reliable 
evidence of an increasing prevalence is from surveys 
which have been repeated with an interval of at least 
10 yr in the same areas, using the same methods and 
the same epidemiological definitions (positive answers 
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to validated questions) on each occasion. All such 
studies have shown an increased prevalence of asthma 
(1,5). The same trends were observed in general prac- 
tice surveys conducted in England and Wales (6). 
Despite a possible change in recognition of asthma by 
physicians, the results of these studies probably reflect 
a true change because both asthma symptoms and 
allergic rhinitis have also increased (5,7). 
However, there are insufficient comparable data 
about the current prevalence of asthma as most 
epidemiological studies have used different methods 
to study different populations; therefore discrepan- 
cies of reported prevalence between countries are 
difficult to interpret. For this reason Burney et al. 
initiated the European Community’s Concerted 
Action on Asthma Prevalence and Risk Factors (the 
European Community Respiratory Health Survey: 
(ECRHS). The study aimed to assess the prevalence 
and risk factors of asthma and asthma-like symp- 
toms in several areas of different countries using a 
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standardized protocol, which includes two stages: a 
postal questionnaire sent to representative samples of 
populations (stage I) and a full length questionnaire 
with further tests in subsamples of those subjects who 
answered the postal questionnaires (stage II) (89). 
We present herein the prevalences of reported 
asthma, asthma-like symptoms and nasal allergies, 
their relationships to age group and sex, and the rela- 
tionships of asthma-like symptoms to current asthma 
in the general population (aged 20-44 years) of three 
geographically different French urban areas, using the 
protocol of the screening stage of the ECRHS. 
Methods 
THE SAMPLES 
Five French centres participated in the first stage 
of ECRHS and performed the study independently in 
1991 and 1992. Approval by the National Ethics 
Committee was obtained centrally for the five cen- 
tres, and permission for computerized data process- 
ing was obtained by each centre from the National 
Committee for Data Processing and Freedom. 
Anonymous joint computerization of the data was 
arranged by three centres in view of common analy- 
ses. The results of these centres are reported herein. 
The three study areas were the entire cities of (i) 
Grenoble and (ii) Montpellier, and (iii) the 18th 
district of Paris. These are urban areas in different 
geographical locations: Grenoble is located in the 
Alps, at low altitude; Montpellier is a Mediterranean 
city; and the 18th district is one of the 20 inner-city 
administrative units of Paris. 
The study areas were selected according to the 
guidelines of the ECRHS, i.e. using pre-existing 
administrative boundaries with total population of 
around 150 000, from which a representative sample 
of a minimum of 3000 subjects (1500 of each sex) 
aged 20-44 years should be included in the study. In 
the three areas, electoral rolls were used as sampling 
frames. Random samples were obtained by simple 
random sampling in Paris and stratified by sex in 
Montpellier and Grenoble. Since electoral rolls are 
not constantly updated, we considered that all the 
subjects whose unopened questionnaires were 
returned by the post office marked ‘not known’ 
were outside the sampling frame and not eligible to 
take part in the study. After excluding those subjects, 
the sample size was 3703 in Grenoble, 5619 in 
Montpellier and 4299 in Paris. 
QUESTIONNAIRE 
The prevalence of asthma and asthma-like symp- 
toms was assessed by a simple self-administered 
questionnaire (screening questionnaire of the 
ECRHS) (8), sent by post. 
Seven questions were about the following symp- 
toms in the last 12 months: 
(1) Wheezing; 
(1.1) Wheezing with breathlessness; 
(1.2) Wheezing apart from colds; 
(2) Waking up with a feeling of tightness in the chest 
(chest tightness); 
(3) Being woken by an attack of shortness of breath 
(nocturnal shortness of breath); 
(4) Being woken by an attack of coughing (nocturnal 
coughing); 
(5) Attack of asthma (current asthma). 
Two more questions dealt with: 
(6) Current asthma medications (asthma medi- 
cation); and 
(7) Nasal allergies including hay fever (nasal 
allergies). 
The questions were translated into French by two 
translators, then translated back into English by an 
independent translator. the latter translation was 
then compared with the original version and any 
discrepancy in the wording led to changes in the 
French version. 
The question ‘Have you ever had attacks of 
asthma?’ (asthma-ever) was added to allow compari- 
son of the results of the present study with previous 
studies conducted in large samples of the French 
population. 
STUDY DESIGN 
The questionnaire was sent by post accompanied 
by an information letter without mention of asthma. 
The initial mailing was followed by up to two 
reminder letters in Grenoble and Montpellier, and up 
to three reminder letters and a telephone call, when- 
ever possible, in Paris. In Grenoble, a random sample 
of 100 non-respondents was visited at home to assess 
the reasons for non-response. 
STATISTICAL ANALYSIS 
The SAS-PC statistical package was used for 
statistical analysis. Associations between categorical 
variables were tested by chi-square tests. The variable 
‘response status’ was constructed: subjects were clas- 
sified into five categories in Paris and three categories 
in Grenoble and Montpellier, according to whether 
they had responded to the initial mailing or to one of 
the various reminders. 
The relationships of asthma-like symptoms and 
nasal allergies to current asthma were determined as 
odds-ratios. 
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Mantel-Haenszel chi-square was used to test linear 
trends in the associations between age groups and 
morbidity. 
Results 
PARTICIPATION 
In Grenoble, 2804 subjects responded to the ques- 
tionnaire, 3774 in Montpellier and 3152 in Paris. Ad- 
justed response rates* were 77g%, 68.6% and 74.4%, 
respectively. The rate was slightly higher among women 
in Grenoble (79.7% vs. 76.0% among men, P=O.O08) 
and in Montpellier (69.9”/0 vs. 67.4%, P=O.O04), but not 
in Paris. There was no significant relationship between 
response rate and age in Grenoble. In Paris, response 
rate was slightly but significantly higher for the young- 
est (8 1.3”% in those aged 20-24 years) and lower for the 
oldest age groups (73.0% in those aged 4044 years). 
The ages of non-respondents were not known for the 
Montpellier sample. 
The age distributions in the selected samples were 
significantly different from those of the area popula- 
tions according to the 1990 census data. As expected, 
the young were under-represented, since their enrol- 
ment in the electoral roll is often delayed. In Greno- 
ble, the proportion of those aged 20-24 years was 
12.5% in the selected sample and 13.0% in respond- 
ents vs. 29.0% in the census population. In Paris, the 
corresponding proportions were 10.4%, 11.3% and 
17.0%, respectively. In Montpellier, the proportion of 
20-24-year-olds was 12.2% among respondents vs. 
31.5% in the census population. 
The respondents were classified into five age 
groups (20-24 years, 25-29 years, 30-34 years, 35539 
years and 4044 years). The proportions of those 
aged 20-24 yeas were less than 13%, the proportions 
of subjects in each of the three intermediate age 
groups were approximately 20%, and the proportions 
of those aged 4044 years were greater than 28%. The 
percentages of men among respondents were 49.3% 
in Grenoble, 50.3% in Montpellier and 46.4% in 
Paris, and were not significantly different between the 
five age groups for any of the three areas. 
We assessed a possible over-representativity of 
symptomatic subjects among respondents by testing 
the relationships between symptoms and response 
status, and by analysing the survey of the 100 non- 
respondents in Grenoble. There were no differences 
in prevalences of symptoms according to the response 
status in any of the three areas, except for nasal 
*Adjusted response rates: respondents/total after exclusion of those 
who died after sampling and those whose questionnaire was filled in 
by another person. 
allergies which were significantly more frequent in 
respondents to the initial mailing both in Montpellier 
and in Paris. Of the 100 non-respondents surveyed, 
55 did not live at their registered address, 33 refused 
to answer and 12 were willing to complete the 
questionnaire. Of these 12 subjects, two reported 
wheezing in the last 12 months, two had been woken 
by chest tightness, three had been woken by an attack 
of coughing, none reported current asthma, and four 
reported nasal allergies. 
PREVALENCE OF ASTHMA AND SYMPTOMS 
Table 1 shows the prevalence of reported asthma, 
asthma-like symptoms and nasal allergies in the three 
areas. Asthma-ever, current asthma, asthma medi- 
cations and nasal allergies were significantly less 
frequent in Grenoble than in the two other areas, and 
nasal allergies were most frequent in Montpellier. 
The proportion of subjects with nocturnal shortness 
of breath, current asthma and/or asthma medication 
(Questions 3, 5 and 6) was 6.6% in Grenoble, 7.2% in 
Montpellier and 7.7% in Paris (not statistically dif- 
ferent). This variable corresponded to the definition 
of the subjects to be included in the symptomatic 
sample of the second stage of ECRHS. 
Table 2 shows the prevalences of the conditions 
studied, separately in males and females, in the three 
areas. The only relationships between symptoms and 
sex were the following: greater frequency of wheezing 
among men than women in Grenoble; greater fre- 
quency among women than men of nocturnal cough- 
ing in the three areas; and greater frequency among 
women than men of chest tightness in Montpellier 
and Paris. 
Few of the symptoms correlated with age. Table 3 
shows the frequencies of the variables that had signifi- 
cant linear trends with age in at least one area. The 
prevalence of curfent asthma was significantly greater 
in the youngest age group in Paris alone, whereas the 
prevalence of asthma-ever and wheezing tended to 
decrease with increasing age in all three areas. 
The relationships of asthma-like symptoms and 
nasal allergies to reported current asthma are shown 
in Table 4. As expected, nasal allergies were six- to 
eight-fold more frequent among current asthmatics 
than non-asthmatics. Among the asthma-like symp- 
toms, wheezing and nocturnal shortness of breath 
correlated strongly with asthma, chest tightness cor- 
related moderately and nocturnal coughing corre- 
lated poorly. Nevertheless all these relationships were 
statistically significant. 
Of those subjects who reported asthma attacks 
in the last 12 months, the percentages of subjects 
currently taking any medicine for asthma were 48.0% 
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Table I Prevalence (%) of reported asthma, asthma-like symptoms and nasal allergies in the 
three areas 
Grenoble Montpellier 
n=2804 ?I=3774 
Paris 
n=3152 
P- 
value 
Wheezing (Question 1) 
Wheezing with breathlessness 
(Question 1.1) 
Wheezing apart from 
colds (Question 1.2) 
Chest tightness (Question 2) 
Nocturnal shortness of 
breath (Question 3) 
Nocturnal coughing 
(Question 4) 
Current asthma (Question 5) 
Asthma medication 
(Question 6) 
Nasal allergies (Question 7) 
Asthma-ever 
(cumulative prevalence) 
14.3 
(13.tLl5.6) 
8.3 
(7.3-9.3) 
10.1 
(9.&l 1.2) 
15.0 
(13.7716.3) 
4.7 
(395.5) 
24.8 
(23.2-26.4) 
2.7 
(2.1-3.3) 
2.1 
(l&2.6) 
28.0 
(26.3-29.7) 
7.4 
(648.4) 
14.0 
(12.9-15.1) 
8.8 
(7.9-9.7) 
8.6 
(7.7-9.5) 
16.7 
(15.5-17.9) 
4.1 
(3.547) 
25.4 
(24.0-26.8) 
3.5 
(2.941) 
3.4 
(2.84.0) 
34.3 
(32.8-35.8) 
9.2 
(8.3-10.1) 
14.4 
(13.2-15.6) 
9.3 
(8.3-10.3) 
8.8 
(7.8-9.8) 
16.7 
(15.4-18.0) 
4.6 
(395.3) 
26.5 
(25.0-28.0) 
4.0 
(3.34.7) 
3.1 
(2.553.7) 
30.8 
(29.2-32.4) 
9.3 
(8.3-10.3) 
n.s. 
ns. 
n.s. 
ns. 
ns. 
n.s. 
0.02 
0.01 
<O.OOl 
0.02 
Values in parentheses indicate 95% confidence limits. 
Table 2 Prevalence (%) of reported asthma, asthma-like symptoms and nasal allergies in the three areas according to sex 
Grenoble Montpellier Paris 
M F P- M F P- M F P- 
ir= 1381 n= 1423 value n= 1899 n= 1875 value n= 1462 n= 1689 value 
16.2 12.4 0.004 14.7 13.2 
9.1 7.6 n.s. 9.0 8.5 
n.s. 14.7 14.2 
n.s. 9.3 9.2 
n.s. 
n.s. 
Wheezing (Question 1) 
Wheezing with breathlessness 
(Question 1.1) 
Wheezing apart from 
colds (Question 1.2) 
Chest tightness (Question 2) 
Nocturnal shortness of 
breath (Question 3) 
Nocturnal coughing 
(Question 4) 
Current asthma (Question 5) 
Asthma medication 
(Question 6) 
Nasal allergies (Question 7) 
Asthma-ever 
(cumulative prevalence) 
11.1 9.1 
13.9 16.1 
4.4 4.9 
21.3 28.2 
8.9 8.3 
14.5 18.9 
3.7 4.6 
20.0 30.8 
ns. 8.5 9.1 n.s. n.s. 
<O.OOl 15.1 18.0 
n.s. 4.3 4.9 
<O.OOl 21.6 30.8 
0.03 
n.s. 
<O.OOl 
n.s. 
n.s. 
co.001 
2.8 2.5 
2.2 2.0 
29.2 26.8 
8.0 6.8 
n.s. 3.2 3.8 
n.s. 3.1 3.8 
4.1 4.0 
3.3 3.0 
n.s. 
ns. 
n.s. 
n.s. 
32.9 35.8 
9.2 9.3 
ns. 30.4 31.2 
n.s. 9.5 9.2 
ns. 
ns. 
n.s. 
n.s. 
M, male; F, female. 
in Grenoble, 58.3% in Montpellier and 56.3% in 2.74.1% for current asthma. The true prevalence of 
Paris. asthma in the populations of the areas sampled is 
likely to be greater than observed in the samples for 
Discussion two reasons. Firstly, the prevalences were greater in 
The prevalence of reported asthma was high in the youngest age group, and the youngest were 
each of the three areas: 7+9.4% for asthma-ever and under-represented. Secondly, questions on asthma or 
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Table 3 Prevalence (%) of reported asthma and wheezing according to age group 
20-24 25-29 30-34 35-39 4&44 P- 
Area years years years years years values* 
Wheezing G 16.7 16.5 13.3 14.1 12.4 0.02 
(Question 1) M 17.6 13.5 14.3 14.6 12.1 0.03 
P 16.7 16.4 12.7 15.6 12.7 0.05 
Current asthma G 3.0 2.8 1.8 2.3 3.4 n.s. 
(Question 5) M 4.8 3.6 3.4 3.0 3.2 ns. 
P 5.7 6.4 3.3 3.2 2.9 <O.OOl 
Asthma-ever G 9.9 9.2 I.5 5.7 6.2 0.004 
(cumulative prevalence) M 12.6 9.8 9.6 8.4 7.4 0.00 1 
P 13.9 10.9 8.4 8.6 I.7 0.001 
*Linear trend tests (Mantel-Haenszel); G, Grenoble; M, Montpellier; P, Paris. 
asthma attacks are considered as highly specific (in 
that people who claim to have the disease nearly 
always seem to have it), but seriously insensitive 
(since many subjects are unaware of having asthma 
but would be so diagnosed if clinically investigated) 
(10,ll). 
The participation rates (77.8%, 68.6% and 74.4% in 
Grenoble, Montpellier and Paris, respectively) were 
satisfactory for a postal survey in a general popu- 
lation sample, randomly selected from electoral rolls. 
In two recent studies of population samples from 
electoral rolls, the participation rates were 72% (12) 
and 56% (13). In another study conducted in a 
multistage stratified family cluster sample, 78% of the 
selected subjects were studied (14). Our response rate 
in Paris was obtained following four reminders. This 
is unlikely to have biased the results since the preva- 
lence of asthma and asthma-like symptoms was not 
related to response status. The participation rate in 
the three areas is obviously a conservative figure: 
approximately one-third of the people contacted by 
the telephone reminder in Paris told us that the 
subject selected for the study had left that address at 
least 1 yr previously. Moreover, 55 of the 100 non- 
respondents surveyed in Grenoble were not found at 
their registered address, suggesting that a subsample 
of non-respondents were actually not eligible. In the 
three East Anglian towns participating in the 
ECRHS, the most common cause of non-response 
was that the subject had moved (15). 
The questionnaire of the ECRHS (stage I) included 
questions that had previously been used in epidemio- 
logical studies. The questions on wheezing were 
derived from the first questionnaire about respiratory 
symptoms of the British Medical Research Council 
(MRC questionnaire, 1960) (11). The other questions 
on asthma-like symptoms were developed to measure 
the prevalence of current asthma in large popu- 
lations, since answers to questions on asthma were 
considered to be dependent on access to and use of 
health care, and the questions on wheezing were 
criticized because ‘wheezing’ is not specific enough 
(16). These new questions were included in the 
questionnaire of the International Union Against 
Tuberculosis and Lung Disease (IUATLD question- 
naire, 1986) (11,16,17). The question on nocturnal 
shortness of breath was also introduced in the 1986 
version of the MRC questionnaire. The question 
‘Have you ever had asthma?’ was first used in the 
1978 version of the questionnaire about respiratory 
diseases from the American Thoracic Society and the 
Division of Lung Diseases, National Heart, Lung 
and Blood Institute, U.S.A. (ATS-DLD-78), whereas 
the 1966 and 1986 versions of the MRC question- 
naire asked about ‘bronchial asthma’ (11). The ques- 
tion ‘Have you ever had attacks of asthma?’ has been 
used in French studies since 1976 (5). In the present 
study, we used this question, rather than ‘Have you 
ever had asthma? which might have been more 
sensitive and consequently might have overestimated 
the prevalence, and biased the comparison with 
previous studies. 
We analysed the relationships between current 
reported asthma and current symptoms considered as 
asthma-like. In spite of its poor sensitivity, the ques- 
tion on current asthma identifies subjects who are 
very likely to be asthmatics (10,ll). In the absence of 
a single gold standard, it is legitimate to use it to 
validate the questions on asthma-like symptoms. 
Chest tightness correlated moderately with asthma, 
and nocturnal coughing correlated poorly. Chest 
tightness was initially included in the group of ques- 
tions to be used to select symptomatic subjects for the 
second stage of ECRHS. This question was then 
discarded from the group of questions because a 
large number of subjects who could not be considered 
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Table 4 Odds-ratios for the relationships of asthma-like symptoms and nasal allergies to 
reported current asthma in the three areas 
Grenoble Montpellier Paris 
Wheezing (Question 1) 
Wheezing with breathlessness 
(Question 1.1) 
Wheezing apart from 
colds (Question 1.2) 
Chest tightness (Question 2) 
Nocturnal shortness of 
breath (Question 3) 
Nocturnal coughing 
(Question 4) 
Nasal allergies (Question 7) 
25.5 38.3 21.0 
(17.1-37.8) (28.2-52.1) (154-28.5) 
27.3 35.4 25.2 
(19.2-38.9) (27.0-46.5) (18.9-33.5) 
29.5 24.7 22.3 
(20442.4) (18.8-32.5) (16.7-29.7) 
13.7 11.6 17.7 
(9.2-20.2) (8.5-15.7) (12924.4) 
26.6 27.2 19.1 
(18.7-37.9) (20.5-36.1) (13.9-26.1) 
3.0 4.4 2.9 
(1.947) (3.2-6.1) (2.0-4.1) 
6.7 5.7 8.0 
(4.3-10.4) (4.0-8.1) (5611.5) 
Values in parentheses indicate 95% confidence limits. 
to be asthmatics gave a positive answer. Our results 
show that this symptom is less closely related to 
asthma than wheezing and nocturnal shortness of 
breath. The question on nocturnal coughing is even 
less relevant since one subject out of four gave a 
positive answer, and the symptom correlated very 
poorly with asthma. The prevalences of chest tight- 
ness and nocturnal cough observed in our study were 
very similar to those observed among Australian 
adults using the same questions (12). Among the new 
questions, nocturnal shortness of breath seems par- 
ticularly satisfactory according to our results, since 
the odds-ratios towards current asthma were between 
19 and 27, according to the area. When the IUATLD 
questionnaire was tested against bronchial hyper- 
responsiveness, nocturnal shortness of breath seemed 
to be a better predictor than any other question (15). 
About one-half of current asthmatics said that they 
were currently taking medications for asthma. How- 
ever, there is a time discrepancy between the two 
relevant questions: the last 12 months for current 
asthma and present time for current medications. 
We will not compare the prevalence of asthma 
described in this study with other geographical areas, 
because few surveys in other areas employed the 
same methodology. The final international compari- 
son of the results from all the areas participating in 
the ECRHS will provide a much more complete 
comparison than we could. The prevalences of 
asthma and nasal allergies among our samples were 
higher than expected from comparable previous 
studies in France: in two studies of 8140 Parisian 
students in 1968 and 10 559 students in 1982, the 
prevalences were 3.3% and 5.40/o, respectively, for 
asthma-ever, and 3.8% and 10.2%, respectively, for 
allergic rhinitis (5). Among the Parisian subjects aged 
20-24 years in this study, 14.2% reported asthma- 
ever and 28.3% reported allergic rhinitis. The true 
increase is probably greater than that observed, since 
university students are believed to have a higher 
prevalence of asthma than the general population 
(16). These results are consistent with an increase of 
asthma and allergy. Practically all repeat surveys 
of asthma throughout the world, spanning periods of 
10 yr or more, have shown similar increases both in 
adults (11,19) and in children or adolescents (1,ZO). 
This increase in the prevalence of asthma and 
asthma-like symptoms cannot be due to the study 
methodology since the questions used in all these 
studies were the same on the first and second 
occasions. Possible changes in asthma recognition 
and artefacts of diagnosis have been studied, but 
they do not seem to account for the increase (4). 
Further evidence has been provided by some studies 
on the increase of asthma prevalence. Haahtela 
et aZ. found that the proportion of men exempted 
from military service because of disabling asthma had 
risen five-fold between 1966 and 1989 whereas the 
proportion of men exempted for other somatic causes 
had not increased (19). Shaw et al. showed that the 
prevalence of asthma and wheeze increased from 
1975 to 1989, but that wheezing associated with colds 
had not, suggesting that the change observed was not 
related to changes in the use or understanding of the 
word ‘wheezing’ (20). Other allergic diseases, such as 
atopic eczema, also seem to be increasing (21). 
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The prevalence of asthma and its associated symp- 
toms was higher in the 20-24-year-old group than 
among the older age groups. This is also consistent 
with an increasing prevalence of asthma. The preva- 
lence of asthma is believed to be at its highest during 
childhood, to fall during adolescence, to remain fairly 
constant between ages 2044 years and to increase 
again after age 45 years (1,22). Thus, the higher 
prevalences in the youngest age group suggests that 
these subjects belong to generations which have a 
more frequent incidence of asthma (23) 
As expected, we did not observe any relationship 
between asthma and sex, since prevalence is generally 
similar among men and women in adults (1, 18). In 
our study of Parisian students in 1982, the male 
predominance of asthma, which is common among 
children (1,24), was only observed in those aged less 
than 21 years (5). 
The prevalence of asthma differed between the 
three areas studied: current asthma and asthma-ever 
were less frequent in Grenoble than in Montpellier 
and Paris, whereas nasal allergies were more fre- 
quent in Montpellier than in the two other areas. 
Neither age nor sex can explain these differences: 
the age distributions of responders were similar in 
the three areas, and sex was not related to these 
conditions. 
In conclusion, the major results of this study were: 
(i) the prevalence of asthma was higher than expected 
from previous studies; (ii) that prevalence was higher 
in the youngest age group; and (iii) that prevalence 
was significantly lower in one of the three areas, 
Grenoble, which is a low altitude city in the Alps. 
These results are likely to be explained by changes 
over time and differences between the areas in en- 
vironmental factors. Stage II of ECRHS, completed 
by further data collection, will enable us to consider 
the indoor environment, including mite allergen 
measurements, as well as outdoor pollution and 
pollen counts, which can be involved in the differ- 
ences observed. 
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